Tell us what you think about Healio

  • News Wire Alerts
  • RSS Feeds
  • Dermatology

  • x

Loading...

  • Sign in for a personal experience.

    Customized content served to meet your interests.

  • All Specialties
  • Dermatology
  • Subspecialties
    • All Dermatology
    • Acne
    • Aesthetic/Cosmetic Surgery
    • Cutaneous Oncology
    • Dermatitis
    • Dermatopathology
    • Dermoscopy
    • Geriatrics
    • Immunology
    • Lasers
    • Pediatric Dermatology
    • Practice Management
    • Psoriasis
    • Skin Care
    • Wound Management
  • All Specialties
  • Adolescent Medicine
  • Allergy/Immunology
  • Cardiology
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Geriatric Medicine
  • Health Professions
  • Hematology/Oncology
  • Hepatology
  • Infectious Disease
  • Nursing
  • Ophthalmology
  • Optometry
  • Orthopedics
  • Orthotics/Prosthetics
  • Pediatrics
  • Psychiatry
  • Rheumatology
  • Sports Medicine
  • News
    • All News
    • Meeting News Coverage
  • Video
  • Education Lab/CME
    • Education Lab Home
    • CME
  • Books
  • Meetings
    • Meetings/Courses
    • Meeting News Coverage
  • Careers

Healio › Dermatology › News

  • FDA approvals
  • FDA approves Sensus Healthcare’s SRT-100 for keloid treatment

  • May 24, 2013
  • Sensus Healthcare announced today that it has received FDA clearance to treat keloids caused by surgery or injury with its superficial radiotherapy...More »
  • In the Journals
  • Use of sun protection for young Australian children increased

  • May 24, 2013
  • While sun exposure in early childhood did not decrease during an 8-year period in Australia, the reported use of sun protection did, according to study...More »
  • ‘Don’t Fry Day’ encourages skin cancer prevention measures

  • May 23, 2013
  • Friday has been designated “Don’t Fry Day” by the Environmental Protection Agency, the National Center for Skin Cancer Prevention, the...More »
  • Perspective
  • Clinicians offer insights into promising drugs in the pipeline

  • May 22, 2013
  • The May 25 issue of HemOnc Today includes the annual Oncology Drugs in the Pipeline chart, which lists drugs in phase 2 or phase 3 development for a...More »
  • In the Journals
  • Alopecia areata related to high prevalence of comorbid conditions

  • May 22, 2013
  • Patients with alopecia areata had a high prevalence of comorbid conditions, according to study results published today.
    In a retrospective cross-sectional...More »
  • In the Journals
  • Surgeon errors among factors for tumor recurrence after MMS

  • May 22, 2013
  • Surgeon errors resulting in persistent unexcised tissue, tissue drop out and aggressive tumor types were significant factors with tumor recurrence after...More »
  • FDA public health advisories
  • Sandoz conducting recall of methotrexate sodium

  • May 21, 2013
  • Sandoz is conducting a voluntary, nationwide recall of two lots of its methotrexate sodium, USP, 25 mg/mL, 40 mL vial injectable drug because it...More »
  • In the Journals
  • Appearance played important role in female students’ use of self-tanners

  • May 21, 2013
  • Female college students’ appearance schema played a key role in creating their attitudes about sunless tanning product use, according to recent...More »
  • Health Care Legislative and Regulatory Update
  • BLOG: Inpatient admission or observation services: Do we finally have some clarity?

  • May 20, 2013
  • From international law firm Arnold & Porter LLP comes timely views on current regulatory and legislative topics that weigh on the minds of today’s...More »
  • Meeting News Coverage Perspective
  • Ipilimumab plus nivolumab induced long-lasting tumor shrinkage in advanced melanoma

  • May 20, 2013
  • Combination therapy with ipilimumab and the investigational antibody nivolumab led to lasting tumor shrinkage in about half of patients with aggressive,...More »
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Featured
  • Most Popular
  • FDA approvals
  • FDA approves Sensus Healthcare’s SRT-100 for keloid treatment

  • May 24, 2013
  • 3 Important Risk Factors for Melanoma

  • May 25, 2013
  • Books
  • Curbside Consultation in Pediatric Dermatology: 49 Clinical Questions

  • James Treat, MD
    2012; ISBN 1-61711-003-5
  • 3 Important Risk Factors for Melanoma

  • May 25, 2013
  • In the Journals
  • MEK inhibitor shows activity in NRAS-mutated melanoma

  • May 17, 2013
  • FDA approvals
  • FDA approves Sensus Healthcare’s SRT-100 for keloid treatment

  • May 24, 2013

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

See related story »

View past polls »

Advertisement
  • Resources from Industry
Account Information
  • Create New User
  • Login
  • Subscribe Or Buy
  • Help
Healio.com
  • About Healio
  • Publications
  • Editorial Board
  • Contact the News Desk
  • Contact Us
  • About the Wyanoke Group
  • Advertising Information
  • Reprints
  • Sitemap
Legal
  • Medical Disclaimer
  • Privacy Policy
  • Editorial Policy and Philosophy
  • Terms and Conditions
  • Permissions
Connect with Healio
  • Twitter
  • Facebook
  • RSS Feeds

©2013 All Rights Reserved.